Exports of SII vaccine blocked till March-April

NEW DELHI: Exports of the Oxford-AstraZeneca vaccine by the Serum Institute of India are currently blocked until March or April, as India look set to take the lead in driving the region's distribution efforts in the months ahead, according to Moodys Analytics. India has approved two vaccines approved for emergency use last week – one developed by Oxford University and AstraZeneca, the other domestically developed by Bharat Biotech and ICMR.